ATS Core Curriculum 2014: part I. Adult pulmonary medicine
- PMID: 25237992
- PMCID: PMC5467102
- DOI: 10.1513/AnnalsATS.201406-262CME
ATS Core Curriculum 2014: part I. Adult pulmonary medicine
Keywords: lung cancer; pleural effusions; pneumoconioses; pneumonia; tuberculosis.
Similar articles
-
ATS Core Curriculum 2017: Part IV. Adult Pulmonary Medicine.Ann Am Thorac Soc. 2017 Aug;14(Suppl_2):S196-S208. doi: 10.1513/AnnalsATS.201702-185CME. Ann Am Thorac Soc. 2017. PMID: 28857625 Review. No abstract available.
-
Are some people not safer after successful treatment of tuberculosis?Am J Respir Crit Care Med. 2005 Jun 15;171(12):1324-5. doi: 10.1164/rccm.2502005. Am J Respir Crit Care Med. 2005. PMID: 15941841 No abstract available.
-
The tuberculosis X factor.Lancet Infect Dis. 2006 Nov;6(11):679. doi: 10.1016/S1473-3099(06)70604-1. Lancet Infect Dis. 2006. PMID: 17067912 No abstract available.
-
ATS Core Curriculum 2016: Part III. Pediatric Pulmonary Medicine.Ann Am Thorac Soc. 2016 Jun;13(6):955-66. doi: 10.1513/AnnalsATS.201602-097CME. Ann Am Thorac Soc. 2016. PMID: 27295156 Free PMC article. No abstract available.
-
ATS Core Curriculum 2017: Part III. Adult Critical Care Medicine.Ann Am Thorac Soc. 2017 Aug;14(Suppl_2):S182-S195. doi: 10.1513/AnnalsATS.201702-180CME. Ann Am Thorac Soc. 2017. PMID: 28857624 Review. No abstract available.
Cited by
-
The 6-Minute Walk Test: Indications and Guidelines for Use in Outpatient Practices.J Nurse Pract. 2022 Jun;18(6):608-610. doi: 10.1016/j.nurpra.2022.04.013. Epub 2022 May 12. J Nurse Pract. 2022. PMID: 35578650 Free PMC article.
-
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.Mediators Inflamm. 2017;2017:8909834. doi: 10.1155/2017/8909834. Epub 2017 Jun 1. Mediators Inflamm. 2017. PMID: 28659665 Free PMC article. Review.
-
Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis.Eur Respir J. 2016 Dec;48(6):1751-1763. doi: 10.1183/13993003.01012-2016. Epub 2016 Nov 11. Eur Respir J. 2016. PMID: 27836953 Free PMC article. Review.
References
-
- Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, et al. TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155–2166. - PubMed
-
- Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD Thibela TB Study Team. A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med. 2014;370:301–310. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources